Login | English | Deutsch

 Forschungsinformationssystem Universität Greifswald




Originalartikel | erschienen - Druck | peer reviewed | Open Access

Randomized, placebo-controlled study on efficacy, safety and tolerability of drug-induced defibrinogenation for sudden sensorineural hearing loss: the lessons learned.


EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 2023 / März ; 280(9): 4009 - 4018






Bibliometrische Indikatoren



Impact Factor = 1,9

Zitierhäufigkeit nach WOS = 3

DOI = 10.1007/s00405-023-07896-z

PubMed-ID = 36881166


Autoren

Weiss B*, Spiegel J, Becker S, Strieth S, Olzowy B, Bertlich M, Fořt T, Mejzlik J, Lenarz T, Ihler F1, Canis M


Abstract

Disturbance of cochlear microcirculation is discussed as final common pathway of various inner ear diseases. Hyperfibrinogenemia causing increased plasma viscosity is a possible factor for a critical reduction of cochlear blood flow that might lead to sudden sensorineural hearing loss (SSHL). The aim was to determine the efficacy and safety of drug-induced defibrinogenation by ancrod for SSHL.

Veröffentlicht in

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY


Jahr 2023
Monat/Hj. März
Impact Factor (2023) 1,9
Volume 280
Issue 9
Seiten 4009 - 4018
Open Access ja
Peer reviewed ja
Artikelart Originalartikel
Artikelstatus erschienen - Druck
DOI 10.1007/s00405-023-07896-z
PubMed-ID 36881166

Allgemeine Daten zur Fachzeitschrift

Kurzbezeichnung: EUR ARCH OTO-RHINO-L
ISSN: 0937-4477
eISSN: 1434-4726
Land: GERMANY (FED REP GER)
Sprache: English
Kategorie(n):
  • OTORHINOLARYNGOLOGY


Impact Factor Entwicklung

Jahr Impact Factor
2008 0,843
2009 1,167
2010 1,214
2011 1,287
2012 1,458
2013 1,608
2014 1,545
2015 1,627
2016 1,66
2017 1,546
2018 1,75
2019 1,809
2020 2,503
2021 3,236
2022 2,6
2023 1,9
2024 2,2

FAQs | Impressum | Datenschutz